Recent Updates
Recently added Catalysts
HBIO Positive Sentiment Score: 70/100

Harvard Bioscience to Present at Southwest IDEAS Investor Conference on November 16, 2023

Thursday, November 9, 2023 2 min read
Key Takeaway: Harvard Bioscience, Inc. (Nasdaq: HBIO) will present at the Southwest IDEAS Investor Conference on November 16, 2023. The presentation will be led by CEO Jim Green and CFO Jennifer Cote at The Statler in Dallas, Texas. Attendees will be able to register for the conference and schedule one-on-one meetings with company representatives. A replay of the presentation will be made available on the company's Investor Relations website after the event.

Market Sentiment Analysis

POSITIVE FACTORS

  • Harvard Bioscience has a prominent opportunity to present to investors.
  • The event may strengthen relationships with potential investors and partners.
  • The company is actively engaging in investor relations by hosting one-on-one meetings.

Full Press Release Details

HOLLISTON, Mass., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and Chief Executive Officer Jim Green will present to investors at the Southwest IDEAS Investor Conference on Thursday November 16, 2023 at The Statler in Dallas, Texas. Joining him will be Jennifer Cote, the company’s Chief Financial Officer and Treasurer.
The Company’s presentation will begin at 9:40 AM ET / 8:40 AM CT on November 16th. A replay of the presentation will be available on the Investor Relations section Harvard Bioscience website shortly after the presentation has concluded.
Harvard Bioscience will also host one-on-one meetings with investors on Thursday, November 16. To register for the conference or to schedule a one-on-one meeting, please visit https://www.threepartadvisors.com/southwest.
About Harvard Bioscience
Harvard Bioscience, Inc. is a leading developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, pharmaceutical and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. Our customers range from renowned academic institutions and government laboratories to the world’s leading pharmaceutical, biotechnology and contract research organizations. With operations in North America, Europe, and China, we sell through a combination of direct and distribution channels to customers around the world.
For more information, please visit our website at www.harvardbioscience.com.
Harvard Bioscience, Inc.
Investor Relations investors@harvardbioscience.com

Frequently Asked Questions

When will Harvard Bioscience present at the investor conference?

Harvard Bioscience will present on November 16, 2023, at 9:40 AM ET.

Who will join Jim Green during the presentation?

Jennifer Cote, the CFO and Treasurer, will join Jim Green.

Where is the Southwest IDEAS Investor Conference being held?

The conference will take place at The Statler in Dallas, Texas.

How can I access the presentation replay?

The replay will be available on the Harvard Bioscience Investor Relations website.

What services does Harvard Bioscience offer?

The company provides technologies for life science research and therapy development.

Tags: HBIO Viatris Investor Conferences Healthcare Harvard Bioscience investor conference Southwest IDEAS Dallas
Last updated: Nov 9, 2023